Research & Innovation

The research arm of AIG Hospitals, driven through its translational ecosystem under the Asian Healthcare Foundation, is built on a singular vision, bringing laboratory science closer to the patient bedside. With a strong focus on gastrointestinal, metabolic, and microbiome-driven diseases, AIG has developed a robust research infrastructure that combines advanced genomics, clinical data, and interdisciplinary collaboration. The emphasis is not just on discovery, but on generating evidence that directly informs clinical practice, making treatments more precise, personalized, and effective for the Indian population and beyond.

Key research pillars include:

• Centre for Gut Microbiome Research – Exploring the role of gut bacteria in diseases like IBD, obesity, liver disorders, and beyond, with a focus on personalized medicine.
• Prof. Barry Marshall Centre for H. pylori Research – In collaboration with Nobel Laureate Barry Marshall, advancing understanding of H. pylori, antibiotic resistance, and gastric disease pathways.
• Asian Centre for Endocrine Pancreatic Research – Dedicated to early detection, risk stratification, and precision management of pancreatic and metabolic disorders.
• Biobank Facility – A state-of-the-art repository enabling large-scale genomic, biomarker, and translational research for future-ready healthcare solutions.

Together, these initiatives reflect AIG's commitment to building a research-driven healthcare ecosystem where every scientific insight translates into better patient outcomes.